Collection 5 (Sep 2024 - Aug 2025) Articles

Articles
Maturation of Lipid Management in the 2025 ACC/AHA Acute Coronary Syndrome Guideline: What It Is and What It Might Have Been
Brandts J, Ray KK
Journal:
J Am Coll Cardiol

First published: June 10, 2025 DOI: 10.1016/j.jacc.2025.04.024
View
- Share
Articles
ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis
Fukami H, Oike Y
Journal:
J Atheroscler Thromb

First published: June 5, 2025 DOI: 10.5551/jat.RV22038
View
- Share
Articles
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies
Barkas F, Brandts J, De Bacquer D, et al.
Journal:
J Am Coll Cardiol

First published: June 3, 2025 DOI: 10.1016/j.jacc.2025.04.010
View
- Share
Articles
Comparison of coronary artery calcification in breast cancer survivors with age matched controls: A prospective case-control study
Sreevatsa A, Sreedhara Rao Nadig S
Journal:
J Clin Oncol

First published: May 28, 2025 DOI: 10.1200/JCO.2025.43.16_suppl.e24017
View
- Share
Articles
Estimating the Global Impact of Lp(a) Across Different Thresholds and Populations: Challenges for Personalized Risk Prediction
Blankstein R, Berman A, Shiyovich A, et al.
Journal:
JACC

First published: May 26, 2025 DOI: 10.1016/j.jacc.2025.04.032
View
- Share
Articles
Lipoprotein(a) and High-Risk Coronary Plaque: Dawn of a New Era in Assessment and Management of Vulnerable Plaque
Wee S, Ahn J, Kang D, et al.
Journal:
JACC

First published: May 26, 2025 DOI: 10.1016/j.jacc.2025.04.029
View
- Share
Articles
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy
Erlinge D, Tsimikas S, Maeng M, et al.
Journal:
JACC

First published: May 26, 2025 DOI: 10.1016/j.jacc.2025.04.013
View
- Share
Articles
The aspirin heart disease prevention conundrum
Superko HR, Sninsky J, Garrett B
Journal:
Am J Prev Cardiol

First published: May 21, 2025 DOI: 10.1016/j.ajpc.2025.101013
View
- Share
Articles
Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial
Wiegman A, Peterson AL, Hegele RA, et al.
Journal:
Circulation

First published: May 20, 2025 DOI: 10.1161/CIRCULATIONAHA.124.073233
View
- Share
Articles
Performance of PREVENT and pooled cohort equations for predicting 10-Year ASCVD risk in the UK Biobank
Ambrosio M, Alebna PL, Lee T, et al.
Journal:
Am J Prev Cardiol

First published: May 18, 2025 DOI: 10.1016/j.ajpc.2025.101009
View
- Share
Articles
Three-decade analysis of regional disparities in metabolic risk factor related ischemic heart disease mortality: Contrasting trends between South Asia and North America
Nadeem B, Lorlowhakarn K, Ur Rahman S, et al.
Journal:
Int J Cardiol Cardiovasc Risk Prev

First published: May 9, 2025 DOI: 10.1016/j.ijcrp.2025.200425
View
- Share
Articles
Association between multiple complications of pregnancy and risk of cardiovascular disease in a large cohort
Jingyi L, Qingping X, Yingru L, et al.
Journal:
Int J Cardiol Cardiovasc Risk Prev

First published: May 7, 2025 DOI: 10.1016/j.ijcrp.2025.200422
View
- Share

1 2 3 4 5 … 10

Collection 5 (Sep 2024 - Aug 2025) Articles

Articles

Maturation of Lipid Management in the 2025 ACC/AHA Acute Coronary Syndrome Guideline: What It Is and What It Might Have Been

Brandts J, Ray KK

Articles

ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis

Fukami H, Oike Y

Articles

Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies

Barkas F, Brandts J, De Bacquer D, et al.

Articles

Comparison of coronary artery calcification in breast cancer survivors with age matched controls: A prospective case-control study

Sreevatsa A, Sreedhara Rao Nadig S

Articles

Estimating the Global Impact of Lp(a) Across Different Thresholds and Populations: Challenges for Personalized Risk Prediction

Blankstein R, Berman A, Shiyovich A, et al.

Articles

Lipoprotein(a) and High-Risk Coronary Plaque: Dawn of a New Era in Assessment and Management of Vulnerable Plaque

Wee S, Ahn J, Kang D, et al.

Articles

Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy

Erlinge D, Tsimikas S, Maeng M, et al.

Articles

The aspirin heart disease prevention conundrum

Superko HR, Sninsky J, Garrett B

Articles

Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial

Wiegman A, Peterson AL, Hegele RA, et al.

Articles

Performance of PREVENT and pooled cohort equations for predicting 10-Year ASCVD risk in the UK Biobank

Ambrosio M, Alebna PL, Lee T, et al.

Articles

Three-decade analysis of regional disparities in metabolic risk factor related ischemic heart disease mortality: Contrasting trends between South Asia and North America

Nadeem B, Lorlowhakarn K, Ur Rahman S, et al.

Articles

Association between multiple complications of pregnancy and risk of cardiovascular disease in a large cohort

Jingyi L, Qingping X, Yingru L, et al.

Articles

Maturation of Lipid Management in the 2025 ACC/AHA Acute Coronary Syndrome Guideline: What It Is and What It Might Have Been

Brandts J, Ray KK

Share

Articles

ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis

Fukami H, Oike Y

Share

Articles

Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies

Barkas F, Brandts J, De Bacquer D, et al.

Share

Articles

Comparison of coronary artery calcification in breast cancer survivors with age matched controls: A prospective case-control study

Sreevatsa A, Sreedhara Rao Nadig S

Share

Articles

Estimating the Global Impact of Lp(a) Across Different Thresholds and Populations: Challenges for Personalized Risk Prediction

Blankstein R, Berman A, Shiyovich A, et al.

Share

Articles

Lipoprotein(a) and High-Risk Coronary Plaque: Dawn of a New Era in Assessment and Management of Vulnerable Plaque

Wee S, Ahn J, Kang D, et al.

Share

Articles

Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy

Erlinge D, Tsimikas S, Maeng M, et al.

Share

Articles

The aspirin heart disease prevention conundrum

Superko HR, Sninsky J, Garrett B

Share

Articles

Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial

Wiegman A, Peterson AL, Hegele RA, et al.

Share

Articles

Performance of PREVENT and pooled cohort equations for predicting 10-Year ASCVD risk in the UK Biobank

Ambrosio M, Alebna PL, Lee T, et al.

Share

Articles

Three-decade analysis of regional disparities in metabolic risk factor related ischemic heart disease mortality: Contrasting trends between South Asia and North America

Nadeem B, Lorlowhakarn K, Ur Rahman S, et al.

Share

Articles

Association between multiple complications of pregnancy and risk of cardiovascular disease in a large cohort

Jingyi L, Qingping X, Yingru L, et al.

Share